Array
(
[id] => 1271
[catid] => 297
[title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/1271.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:24:28
[updatetime] => 2024-01-11 15:24:28
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2023
[guojia] => the European Society of Anaesthesiology and Intens
[pdf] =>
[tjyjyw] =>
[lyyw] => Fibrinogen level assessment is suggested in patients with advanced liver disease undergoing invasive procedures. Evidence level: low；Recommendation grade: weak）
[laiyuan] => 建议对接受侵入性手术的晚期肝病患者进行纤维蛋白原水平评估。（证据级别：低；推荐强度：弱推荐）
[znzldj] => B
[_inputtime] => 1704957868
[_updatetime] => 1704957868
[_nrjc] =>
[_nrsh] =>
)
推荐意见
建议对接受侵入性手术的晚期肝病患者进行纤维蛋白原水平评估。（证据级别：低；推荐强度：弱推荐）
Fibrinogen level assessment is suggested in patients with advanced liver disease undergoing invasive procedures. Evidence level: low；Recommendation grade: weak）
证据评价方法：GRADE
指南质量等级：B
年份：2023
国家：the European Society of Anaesthesiology and Intens
Array
(
[id] => 1272
[catid] => 297
[title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/1272.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:24:28
[updatetime] => 2024-01-11 15:24:28
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2023
[guojia] => the European Society of Anaesthesiology and Intens
[pdf] =>
[tjyjyw] =>
[lyyw] => In acute liver failure, elevated INR does not predict bleeding risk. （Recommendation grade: weak）
[laiyuan] => 在急性肝衰竭患者中，国际标准化比值升高并不能预测出血风险。（推荐强度：弱推荐）
[znzldj] => B
[_inputtime] => 1704957868
[_updatetime] => 1704957868
[_nrjc] =>
[_nrsh] =>
)
推荐意见
在急性肝衰竭患者中，国际标准化比值升高并不能预测出血风险。（推荐强度：弱推荐）
In acute liver failure, elevated INR does not predict bleeding risk. （Recommendation grade: weak）
证据评价方法：GRADE
指南质量等级：B
年份：2023
国家：the European Society of Anaesthesiology and Intens
Array
(
[id] => 1273
[catid] => 297
[title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/1273.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:24:28
[updatetime] => 2024-01-11 15:24:28
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2023
[guojia] => the European Society of Anaesthesiology and Intens
[pdf] =>
[tjyjyw] =>
[lyyw] => We recommend that, in acute liver failure, moderately elevated INR should not be corrected before invasive procedures, with the exception of intracranial pressure monitor insertion.Evidence level: low；Recommendation grade: strong）
[laiyuan] => 我们推荐，在急性肝衰竭患者中，除颅内压检测插入外，INR中度升高的患者在进行侵入性操作前不应进行校正。（证据级别：低；推荐强度：强推荐）
[znzldj] => B
[_inputtime] => 1704957868
[_updatetime] => 1704957868
[_nrjc] =>
[_nrsh] =>
)
推荐意见
我们推荐，在急性肝衰竭患者中，除颅内压检测插入外，INR中度升高的患者在进行侵入性操作前不应进行校正。（证据级别：低；推荐强度：强推荐）
We recommend that, in acute liver failure, moderately elevated INR should not be corrected before invasive procedures, with the exception of intracranial pressure monitor insertion.Evidence level: low；Recommendation grade: strong）
证据评价方法：GRADE
指南质量等级：B
年份：2023
国家：the European Society of Anaesthesiology and Intens
Array
(
[id] => 1274
[catid] => 297
[title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/1274.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:24:28
[updatetime] => 2024-01-11 15:24:28
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2023
[guojia] => the European Society of Anaesthesiology and Intens
[pdf] =>
[tjyjyw] =>
[lyyw] => We suggest individualised peri-operative management of selective serotonin reuptake inhibitor (SSRI) treatment. （Evidence level: moderate；Recommendation grade: weak）
[laiyuan] => 我们建议对选择性血清素再摄取抑制剂（SSRI）的治疗进行个体化的围手术期管理。（证据级别：中；推荐强度：弱推荐）
[znzldj] => B
[_inputtime] => 1704957868
[_updatetime] => 1704957868
[_nrjc] =>
[_nrsh] =>
)
推荐意见
我们建议对选择性血清素再摄取抑制剂（SSRI）的治疗进行个体化的围手术期管理。（证据级别：中；推荐强度：弱推荐）
We suggest individualised peri-operative management of selective serotonin reuptake inhibitor (SSRI) treatment. （Evidence level: moderate；Recommendation grade: weak）
证据评价方法：GRADE
指南质量等级：B
年份：2023
国家：the European Society of Anaesthesiology and Intens
Array
(
[id] => 1275
[catid] => 297
[title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/1275.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:24:28
[updatetime] => 2024-01-11 15:24:28
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2023
[guojia] => the European Society of Anaesthesiology and Intens
[pdf] =>
[tjyjyw] =>
[lyyw] => We suggest individualised pre-operative management of antiepileptic agents, such as valproic acid, which may increase bleeding. （Evidence level: low；Recommendation grade: weak）
[laiyuan] => 我们建议术前对可能会增加出血的抗癫痫药物（如丙戊酸）进行个体化管理。（证据级别：低；推荐强度：弱推荐）
[znzldj] => B
[_inputtime] => 1704957868
[_updatetime] => 1704957868
[_nrjc] =>
[_nrsh] =>
)
推荐意见
我们建议术前对可能会增加出血的抗癫痫药物（如丙戊酸）进行个体化管理。（证据级别：低；推荐强度：弱推荐）
We suggest individualised pre-operative management of antiepileptic agents, such as valproic acid, which may increase bleeding. （Evidence level: low；Recommendation grade: weak）
证据评价方法：GRADE
指南质量等级：B
年份：2023
国家：the European Society of Anaesthesiology and Intens
Array
(
[id] => 1276
[catid] => 297
[title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/1276.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:24:28
[updatetime] => 2024-01-11 15:24:28
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2023
[guojia] => the European Society of Anaesthesiology and Intens
[pdf] =>
[tjyjyw] =>
[lyyw] => We do not recommend pre-operative discontinuation of Gingko biloba extracts. （Evidence level: moderate；Recommendation grade: strong）
[laiyuan] => 我们不建议术前停用银杏叶提取物。（证据级别：中；推荐强度：强推荐）
[znzldj] => B
[_inputtime] => 1704957868
[_updatetime] => 1704957868
[_nrjc] =>
[_nrsh] =>
)
推荐意见
我们不建议术前停用银杏叶提取物。（证据级别：中；推荐强度：强推荐）
We do not recommend pre-operative discontinuation of Gingko biloba extracts. （Evidence level: moderate；Recommendation grade: strong）
证据评价方法：GRADE
指南质量等级：B
年份：2023
国家：the European Society of Anaesthesiology and Intens
Array
(
[id] => 1277
[catid] => 297
[title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/1277.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:24:28
[updatetime] => 2024-01-11 15:24:28
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2023
[guojia] => the European Society of Anaesthesiology and Intens
[pdf] =>
[tjyjyw] =>
[lyyw] => We suggest the use of bleeding assessment tools (BATs) for detecting and predicting the peri-operative risk of bleeding before surgery and invasive procedures in patients with suspected or confirmed inherited bleeding disorders (IBDs). （Evidence level: moderate；Recommendation grade: weak）
[laiyuan] => 我们建议使用出血评估工具 (BAT)，在疑似或确诊有遗传性出血性疾病 (IBD) 的患者进行手术和侵入性操作前，检测和预测围手术期的出血风险。 （证据级别：中；推荐强度：弱推荐）
[znzldj] => B
[_inputtime] => 1704957868
[_updatetime] => 1704957868
[_nrjc] =>
[_nrsh] =>
)
推荐意见
我们建议使用出血评估工具 (BAT)，在疑似或确诊有遗传性出血性疾病 (IBD) 的患者进行手术和侵入性操作前，检测和预测围手术期的出血风险。 （证据级别：中；推荐强度：弱推荐）
We suggest the use of bleeding assessment tools (BATs) for detecting and predicting the peri-operative risk of bleeding before surgery and invasive procedures in patients with suspected or confirmed inherited bleeding disorders (IBDs). （Evidence level: moderate；Recommendation grade: weak）
证据评价方法：GRADE
指南质量等级：B
年份：2023
国家：the European Society of Anaesthesiology and Intens
Array
(
[id] => 1278
[catid] => 297
[title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/1278.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:24:28
[updatetime] => 2024-01-11 15:24:28
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2023
[guojia] => the European Society of Anaesthesiology and Intens
[pdf] =>
[tjyjyw] =>
[lyyw] => Patients with IBDs are at higher risk of peri-operative bleeding and should be managed in collaboration with a haematologist, preferably in dedicated centres with expertise in coagulation disorders. （Evidence level: moderate；Recommendation grade: weak）
[laiyuan] => 遗传性出血性疾病患者围手术期出血的风险较高，应与血液科医生合作进行管理，最好是在具有凝血功能障碍专家的专门中心进行管理。 （证据级别：中；推荐强度：强推荐）
[znzldj] => B
[_inputtime] => 1704957868
[_updatetime] => 1704957868
[_nrjc] =>
[_nrsh] =>
)
推荐意见
遗传性出血性疾病患者围手术期出血的风险较高，应与血液科医生合作进行管理，最好是在具有凝血功能障碍专家的专门中心进行管理。 （证据级别：中；推荐强度：强推荐）
Patients with IBDs are at higher risk of peri-operative bleeding and should be managed in collaboration with a haematologist, preferably in dedicated centres with expertise in coagulation disorders. （Evidence level: moderate；Recommendation grade: weak）
证据评价方法：GRADE
指南质量等级：B
年份：2023
国家：the European Society of Anaesthesiology and Intens
Array
(
[id] => 1279
[catid] => 297
[title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/1279.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:24:28
[updatetime] => 2024-01-11 15:24:28
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2023
[guojia] => the European Society of Anaesthesiology and Intens
[pdf] =>
[tjyjyw] =>
[lyyw] => We suggest individualised pre-operative haemostatic correction depending on the specific disorder, type of surgery and individual factors (bleeding phenotype). （Evidence level: low；Recommendation grade: weak）
[laiyuan] => 我们建议根据具体疾病、手术类型和个体因素（出血表型）进行个性化的术前止血纠正。（证据级别：低；推荐强度：弱推荐）
[znzldj] => B
[_inputtime] => 1704957868
[_updatetime] => 1704957868
[_nrjc] =>
[_nrsh] =>
)
推荐意见
我们建议根据具体疾病、手术类型和个体因素（出血表型）进行个性化的术前止血纠正。（证据级别：低；推荐强度：弱推荐）
We suggest individualised pre-operative haemostatic correction depending on the specific disorder, type of surgery and individual factors (bleeding phenotype). （Evidence level: low；Recommendation grade: weak）
证据评价方法：GRADE
指南质量等级：B
年份：2023
国家：the European Society of Anaesthesiology and Intens
Array
(
[id] => 1241
[catid] => 297
[title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/1241.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:24:27
[updatetime] => 2024-01-11 15:24:27
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2023
[guojia] => the European Society of Anaesthesiology and Intens
[pdf] =>
[tjyjyw] =>
[lyyw] => In patients treated with P2Y12 inhibitors, who need to undergo surgery, postponing surgery for at least 5 days after cessation of ticagrelor and clopidogrel (time from last drug intake to intervention) – and for 7 days in the case of prasugrel – if clinically feasible, should be considered unless the patient is at high risk of an ischaemic event. （Evidence level: moderate；Recommendation grade: weak）
[laiyuan] => 对于接受P2Y12抑制剂治疗且需要接受手术的患者，除非患者发生缺血事件的风险很高。如果临床可行，应考虑将手术推迟至停用替格瑞洛和氯吡格雷后至少5日(从最后一次服药至手术的时间)，普拉格雷则推迟至7日。（证据级别：中；推荐强度：弱推荐）
[znzldj] => B
[_inputtime] => 1704957867
[_updatetime] => 1704957867
[_nrjc] =>
[_nrsh] =>
)
推荐意见
对于接受P2Y12抑制剂治疗且需要接受手术的患者，除非患者发生缺血事件的风险很高。如果临床可行，应考虑将手术推迟至停用替格瑞洛和氯吡格雷后至少5日(从最后一次服药至手术的时间)，普拉格雷则推迟至7日。（证据级别：中；推荐强度：弱推荐）
In patients treated with P2Y12 inhibitors, who need to undergo surgery, postponing surgery for at least 5 days after cessation of ticagrelor and clopidogrel (time from last drug intake to intervention) – and for 7 days in the case of prasugrel – if clinically feasible, should be considered unless the patient is at high risk of an ischaemic event. （Evidence level: moderate；Recommendation grade: weak）
证据评价方法：GRADE
指南质量等级：B
年份：2023
国家：the European Society of Anaesthesiology and Intens
